Christopher Murphy
Foot & Ankle Surgery · Edgewater, FLNPI 1760463848
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,006 of the $2,752 with a category attached, or 72.9%. Arthrex accounts for 79.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $1,369 and has fallen 81.1% since, to $258 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in FL, where the typical reported total is $3,061.
Across 20 payments — averaging $137.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Smith+Nephew$265
- Pacira Pharmaceuticals Incorporated$92
- Merck$90
- Paragon 28, Inc.$79
- Paratek Pharmaceuticals, Inc.$18
- plus $10 from 1 others
What the payments were for
- Travel & lodging$1485%
- Food & beverage$59822%
- Education$2,00673%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 7 | $2,199 |
| Smith+Nephew | 7 | $265 |
| Pacira Pharmaceuticals Incorporated | 1 | $92 |
| Merck | 1 | $90 |
| Paragon 28, Inc. | 2 | $79 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$137
How this compares
$2,752 in reported general payments places this provider in the 45th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 21 | $160 |
| Cephalexin | 24 | $106 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Edgewater
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
- Ettore VulcanoMiami Beach$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.